Tue, Mar 4, 10:00 AM, Zacks
Synageva 4Q Loss Narrower-than-Expected Loss - Analyst Blog
Synageva BioPharma Corp. (GEVA) reported fourth quarter 2013 loss of $1 per share, wider than the year-ago loss of 62 cents per share, but narrower than the Zacks Consensus Estimate of a loss of $1.02 per share.
Thu, Feb 20, 8:21 AM, Zacks
Synageva BioPharma Corp. (GEVA) in Focus: Stock Moves 5.1% Higher - Tale of the Tape
Synageva BioPharma Corp. (GEVA) was a big mover last session, as the company saw its shares rise by over 5% on the day.